JP Morgan Chase
TNXP icon

JP Morgan Chase’s Tonix Pharmaceuticals TNXP Stock Holding History

JP Morgan Chase’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$66.5K Buy
5,524
+856
+18% +$13.2K ﹤0.01% 6054
2025
Q4 		$72.9K Buy
4,668
+653
+16% +$12K ﹤0.01% 6065
2025
Q3 		$97K Buy
4,015
+439
+12% +$16.3K ﹤0.01% 5921
2025
Q2 		$129K Buy
+3,576
New +$93.7K ﹤0.01% 5487
2025
Q1 		– Sell
-173
Closed -$5.7K – 7733
2024
Q4 		$5.7K Buy
+173
New +$3.6K ﹤0.01% 6491
2024
Q3 		– Hold
0
– – – 7677
2024
Q2 		– Hold
0
– – – 7236
2024
Q1 		– Hold
0
– – – 7142
2023
Q4 		– Sell
-6
Closed -$11.3K – 7870
2023
Q3 		$11.3K Sell
6
-4
-40% -$14.6K ﹤0.01% 6222
2023
Q2 		$51.9K Sell
10
-5
-33% -$37.9K ﹤0.01% 5705
2023
Q1 		$173K Buy
15
+13
+650% +$223K ﹤0.01% 5143
2022
Q4 		$19K Buy
+2
New +$17.3K ﹤0.01% 5908
2022
Q3 		– Hold
0
– – – 6372
2022
Q2 		– Hold
0
– – – 6892
2022
Q1 		– Hold
0
– – – 5686
2021
Q4 		– Hold
0
– – – 5798
2021
Q3 		– Hold
0
– – – 5312
2021
Q2 		– Hold
0
– – – 5419
2020
Q4 		– Hold
0
– -$33K – 5931
2020
Q3 		– Hold
0
– – – 5060
2019
Q1 		– Hold
0
– – – 6053
2018
Q4 		– Hold
0
– – – 5947
2018
Q3 		– Hold
0
– -$131K – 5827
2018
Q2 		– Hold
0
– – – 4745
2018
Q1 		– Hold
0
– – – 5631
2017
Q4 		– Hold
0
– – – 5577
2017
Q3 		– Hold
0
– – – 4847
2017
Q2 		– Hold
0
– – – 5217
2016
Q3 		– Hold
0
– -$27K – 4805
2016
Q2 		– Hold
0
– – – 4171
2016
Q1 		– Hold
0
– – – 4941

Other funds holding TNXP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
JHC
Jones Hill Capital New York $466M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

JP Morgan Chase's TNXP Position: Q1 2026 in Review

JP Morgan Chase increased its Tonix Pharmaceuticals (TNXP) stake by 18% in Q1 2026, buying an estimated $13.2K and bringing the position to 5,524 shares worth $66.5K. The position accounts for ﹤0.01% of the portfolio, ranked #6054.

JP Morgan Chase first reported a position in TNXP in Q4 2022 and has held it in 9 quarters since. The position peaked at $173K in Q1 2023. 81 funds tracked by Wall St. Rank hold TNXP as of Q1 2026.

  • JP Morgan Chase held 5,524 shares of Tonix Pharmaceuticals worth $66.5K as of Q1 2026.
  • JP Morgan Chase bought 856 Tonix Pharmaceuticals shares in Q1 2026, an estimated $13.2K.
  • Tonix Pharmaceuticals made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #6054 holding.
  • JP Morgan Chase first reported a position in Tonix Pharmaceuticals in Q4 2022 and has held it in 9 quarters since.
  • JP Morgan Chase's Tonix Pharmaceuticals position peaked at $173K in Q1 2023.
  • 81 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.